Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study.

Dollerup J, Vestbo J, Murray-Thomas T, Kaplan A, Martin RJ, Pizzichini E, Pizzichini MMM, Burden A, Martin J, Price DB.

Clin Epidemiol. 2017 Apr 26;9:231-243. doi: 10.2147/CLEP.S127775. eCollection 2017.

2.

A Risk Assessment Matrix for Public Health Principles: The Case for E-Cigarettes.

Saitta D, Chowdhury A, Ferro GA, Nalis FG, Polosa R.

Int J Environ Res Public Health. 2017 Mar 31;14(4). pii: E363. doi: 10.3390/ijerph14040363.

3.

In Vitro and Ex Vivo Approaches to Evaluate Next-Generation Tobacco and Non-Tobacco Products on Human Blood Platelets.

Spinelli SL, Lannan KL, Loelius SG, Phipps RP.

Appl In Vitro Toxicol. 2017 Mar 1;3(1):110-120. doi: 10.1089/aivt.2016.0034.

4.

Smokeless Tobacco and Stroke - A Clinico-epidemiological Follow-up Study in A Tertiary Care Hospital.

Jena SS, Kabi S, Panda BN, Kameswari BC, Payal, Behera IC, Tripathy SK, Mahanta S.

J Clin Diagn Res. 2016 Oct;10(10):OC40-OC43. Epub 2016 Oct 1.

5.

A systematic review of possible serious adverse health effects of nicotine replacement therapy.

Lee PN, Fariss MW.

Arch Toxicol. 2017 Apr;91(4):1565-1594. doi: 10.1007/s00204-016-1856-y. Epub 2016 Oct 3. Review.

6.

Hyper-resting brain entropy within chronic smokers and its moderation by Sex.

Li Z, Fang Z, Hager N, Rao H, Wang Z.

Sci Rep. 2016 Jul 5;6:29435. doi: 10.1038/srep29435.

7.

Nicotine: A Double-Edged Sword in Atherosclerotic Disease.

Liu CC, Yeh HI.

Acta Cardiol Sin. 2014 Mar;30(2):108-13. Review.

8.

Putting tobacco harm reduction in perspective: is it a viable alternative?

Jhanjee S.

Indian J Med Res. 2016 Jan;143(1):25-9. doi: 10.4103/0971-5916.178583. No abstract available.

9.

Impact of a Workplace Health Promotion Program on Employees' Blood Pressure in a Public University.

Eng JY, Moy FM, Bulgiba A.

PLoS One. 2016 Feb 3;11(2):e0148307. doi: 10.1371/journal.pone.0148307. eCollection 2016.

10.

Evaluation of left atrial mechanical function and atrial conduction abnormalities in Maras powder (smokeless tobacco) users and smokers.

Akcay A, Aydin MN, Acar G, Mese B, Çetin M, Akgungor M, Cabioglu E, Bozoglan O, Ardic I, Çakici M.

Cardiovasc J Afr. 2015 May-Jun;26(3):114-9. doi: 10.5830/CVJA-2014-070.

11.

Regulation in the face of uncertainty: the evidence on electronic nicotine delivery systems (e-cigarettes).

Farsalinos KE, Le Houezec J.

Risk Manag Healthc Policy. 2015 Sep 29;8:157-67. doi: 10.2147/RMHP.S62116. eCollection 2015. Review.

12.

Arrhythmogenic Risk Assessment Following Four-Week Pretreatment With Nicotine and Black Tea in Rat.

Joukar S, Sheibani V, Koushesh F, Ghasemipoor Afshar E, Ghorbani Shahrbabaki S.

Res Cardiovasc Med. 2015 Aug 1;4(3):e27088. doi: 10.5812/cardiovascmed.27088v2. eCollection 2015 Aug.

13.

Time to First Cigarette and Hypertension in Korean Male Smokers.

Lee S, Jang M, Noh HM, Oh HY, Song HJ, Park KH, Paek YJ.

Korean J Fam Med. 2015 Sep;36(5):221-6. doi: 10.4082/kjfm.2015.36.5.221. Epub 2015 Sep 18.

14.

Exploratory survey study of long-term users of nicotine replacement therapy in Danish consumers.

Borup G, Mikkelsen KL, Tønnesen P, Christrup LL.

Harm Reduct J. 2015 Jan 19;12:2. doi: 10.1186/1477-7517-12-2.

15.

Comparison of the characteristics of long-term users of electronic cigarettes versus nicotine replacement therapy: A cross-sectional survey of English ex-smokers and current smokers.

Nelson VA, Goniewicz ML, Beard E, Brown J, Sheals K, West R, Shahab L.

Drug Alcohol Depend. 2015 Aug 1;153:300-5. doi: 10.1016/j.drugalcdep.2015.05.005. Epub 2015 May 18.

16.

Are smoking and passive smoking related with heart rate variability in male adolescents?

Gondim RM, Farah BQ, Santos Cda F, Ritti-Dias RM.

Einstein (Sao Paulo). 2015 Jan-Mar;13(1):27-33. doi: 10.1590/S1679-45082015AO3226. Epub 2015 Mar 3. English, Portuguese.

18.

Association of high blood pressure with body mass index, smoking and physical activity in healthy young adults.

Papathanasiou G, Zerva E, Zacharis I, Papandreou M, Papageorgiou E, Tzima C, Georgakopoulos D, Evangelou A.

Open Cardiovasc Med J. 2015 Feb 27;9:5-17. doi: 10.2174/1874192401509010005. eCollection 2015.

19.

Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence.

Verplaetse TL, Weinberger AH, Smith PH, Cosgrove KP, Mineur YS, Picciotto MR, Mazure CM, McKee SA.

Nicotine Tob Res. 2015 Apr;17(4):486-95. doi: 10.1093/ntr/ntu280. Epub 2015 Mar 11. Review.

20.

Lung function profiles and aerobic capacity of adult cigarette and hookah smokers after 12 weeks intermittent training.

Koubaa A, Triki M, Trabelsi H, Masmoudi L, Zeghal KN, Sahnoun Z, Hakim A.

Libyan J Med. 2015 Feb 17;10:26680. doi: 10.3402/ljm.v10.26680. eCollection 2015.

Supplemental Content

Support Center